Phytochemicals in Cervical Cancer: An Epigenetic Overview

References

• Sung H , FerlayJ , SiegelRLet al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71(3), 209–249 (2021).
   PubMed Web of Science ®Google Scholar
• Ferlay J , ColombetM , SoerjomataramIet al. Cancer Today. International Agency for Research on Cancer. Global Cancer Observatory, Lyon, France (2021).
   Google Scholar
• American Cancer Society. Cancer Facts&Figures 2023.. American Cancer Society, Atlanta, USA (2023). www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2023-cancer-facts-figures.html
   Google Scholar
• WHO . Institut Català d’Oncologia (ICO), Information Centre on HPV and Cervical Cancer (2022): human papillomavirus and related cancers in Egypt. Summ. Rep. Updat.22 (2022).
   Google Scholar
• Chan CK , AimagambetovaG , UkybassovaT , KongrtayK , AzizanA. Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination – review of current perspectives. J. Oncol.2019, 1–11 (2019).
   Web of Science ®Google Scholar
• Lin M , YeM , ZhouJ , WangZP , ZhuX. Recent advances on the molecular mechanism of cervical carcinogenesis based on systems biology technologies. Comput. Struct. Biotechnol. J.17, 241–250 (2019).
   PubMed Web of Science ®Google Scholar
• Wassie M , ArgawZ , TsigeY , AbebeM , KisaS. Survival status and associated factors of death among cervical cancer patients attending at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia: a retrospective cohort study. BMC Cancer19, 1 (2019).
   PubMed Web of Science ®Google Scholar
• Johnson CA , JamesD , MarzanA , CancerAMC. An overview of pathophysiology and management. Semin. Oncol. Nursing Apr.35(2), 166–174 (2019).
   PubMed Web of Science ®Google Scholar
• Castellsagué X . Natural history and epidemiology of HPV infection and cervical cancer. Gynecol. Oncol.1(110), 3 (2008).
   Google Scholar
• García-Closas R , CastellsaguéX , BoschX , GonzálezCA. The role of diet and nutrition in cervical carcinogenesis: a review of recent evidence. Int. J. Cancer117(4), 629–637 (2005).
   PubMed Web of Science ®Google Scholar
• Campos NG , SharmaM , ClarkAet al. The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries. Int. J. Gynecol. Obstet.138, 47–56 (2017).
   PubMed Web of Science ®Google Scholar
• Manaf R , IsmailS , CeciliaN. Global burden of cervical cancer: a literature review. Int. J. Public Heal. Clin. Sci.4(2), (2017).
   Google Scholar
• LaVigne AW , TriedmanSA , RandallTC , TrimbleEL , ViswanathanAN. Cervical cancer in low- and middle-income countries: addressing barriers to radiotherapy delivery. Gynecol. Oncol. Rep.22, 16–20 (2017).
   PubMed Web of Science ®Google Scholar
• Lelchuk A , MorinN , BainK. Squamous cell carcinoma of cervix origin with rare metastasis to the colon. AME Case Rep.2, 23 (2018).
   PubMedGoogle Scholar
• Bhat S , KabekkoduSP , NoronhaA , SatyamoorthyK. Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer. Biochimie121, 298–311 (2016).
   PubMed Web of Science ®Google Scholar
• Sharma A , KulkarniV , BhaskaranUet al. Profile of cervical cancer patients attending tertiary care hospitals of Mangalore, Karnataka: a 4 year retrospective study. J. Nat. Sci. Biol. Med.8(1), 125–129 (2017).
   PubMedGoogle Scholar
• Alay I , KayaC , KaracaIet al. The effect of being diagnosed with human papillomavirus infection on women’s sexual lives. J. Med. Virol.92(8), 1290–1297 (2020).
   PubMed Web of Science ®Google Scholar
• Boda D , DoceaAO , CalinaDet al. Human papillomavirus: apprehending the link with carcinogenesis and unveiling new research avenues (Review). Int. J. Oncol.52(3), 637–655 (2018).
   PubMed Web of Science ®Google Scholar
• Prati B , MarangoniB , BoccardoE. Human papillomavirus and genome instability: from productive infection to cancer. Clinics (Sao Paulo, Brazil)73(Suppl. 1), e539s (2018).
   PubMedGoogle Scholar
• McBride AA , WarburtonA. The role of integration in oncogenic progression of HPV-associated cancers. PLoS Pathogen.13, 4 (2017).
   Web of Science ®Google Scholar
• Gupta SM , Mania-PramanikJ. Molecular mechanisms in progression of HPV-associated cervical carcinogenesis. J. Biomed. Sci.26(1), 28 (2019).
   PubMedGoogle Scholar
• Garbuglia AR , LapaD , SiasC , CapobianchiMR , DelPorto P. The use of both therapeutic and prophylactic vaccines in the therapy of papillomavirus disease. Front. Immunol.11, 188 (2020).
   PubMed Web of Science ®Google Scholar
• Jing Y , WangT , ChenZet al. Phylogeny and polymorphism in the long control regions E6, E7, and L1 of HPV Type 56 in women from southwest China. Mol. Med. Rep.17(5), 7131–7141 (2018).
   PubMed Web of Science ®Google Scholar
• Di-Domenico M , GiovaneG , KouidhiSet al. HPV epigenetic mechanisms related to oropharyngeal and cervix cancers. Cancer Biol. Ther.19(10), 850–857 (2017).
   Web of Science ®Google Scholar
• Yeo-Teh N , ItoY , JhaS. High-risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis. Int. J. Mol. Sci.19(6), 1706 (2018).
   PubMed Web of Science ®Google Scholar
• Martinez-Zapien D , RuizFX , PoirsonJet al. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53. Nature529(7587), 541–545 (2016).
   PubMed Web of Science ®Google Scholar
• Ganti K , BroniarczykJ , ManoubiWet al. The human papillomavirus E6 PDZ binding motif: from life cycle to malignancy. Viruses7(7), 3530–3551 (2015).
   PubMed Web of Science ®Google Scholar
• Kranjec C , TomaićV , MassimiP , NicolaidesL , DoorbarJ , BanksL. The high-risk HPV E6 target scribble (hScrib) is required for HPV E6 expression in cervical tumour-derived cell lines. Papillomavirus Res.2, 70–77 (2016).
   PubMedGoogle Scholar
• Fischer M , UxaS , StankoC , MaginTM , EngelandK. Human papillomavirus E7 oncoprotein abrogates the p53-p21-DREAM pathway. Sci. Rep.7(1), 2603 (2017).
   PubMedGoogle Scholar
• Kgatle MM , SpearmanCW , KallaAA , HairwadziHN. DNA oncogenic virus-induced oxidative stress, genomic damage, and aberrant epigenetic alterations. Oxid. Med. Cell Longev.2017, 1–16 (2017).
   Web of Science ®Google Scholar
• Pop S , EnciuAM , TarcomnicuIet al. Phytochemicals in cancer prevention: modulating epigenetic alterations of DNA methylation. Phytochem. Rev.18, 1005–1024 (2019).
   Web of Science ®Google Scholar
• Fang J , ZhangH , JinS. Epigenetics and cervical cancer: from pathogenesis to therapy. Tumour Biol.35, 5083–5093 (2014).
   PubMedGoogle Scholar
• Bennett RL , LichtJD. Targeting epigenetics in cancer. Annu. Rev. Pharmacol. Toxicol.58(1), 187–207 (2018).
   PubMedGoogle Scholar
• Sen P , GangulyP , GangulyN. Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer. Oncol. Lett.15(1), 11–22 (2018).
   PubMed Web of Science ®Google Scholar
• Stability RW . Stability and flexibility of epigenetic gene regulation in mammalian development. Nature24(447), 7143 (2007).
   Google Scholar
• Okano M , BellDW , HaberDA , LiE. DNA methyltransferases Dnmt3a LED. and Dnmt3b are essential for de novo methylation and mammalian development. Cell29(99), 3 (1999).
   Google Scholar
• Ooi SK , QiuC , BernsteinEet al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature9(448), 7154 (2007).
   Google Scholar
• Arora I , SharmaM , TollefsbolTO. Combinatorial epigenetics impact of polyphenols and phytochemicals in cancer prevention and therapy. Int. J. Mol. Sci.20(18), 4567 (2019).
   PubMed Web of Science ®Google Scholar
• Sundaram MK , UnniS , SomvanshiPet al. Genistein modulates signaling pathways and targets several epigenetic markers in HeLa cells. Genes10(12), 955 (2019).
   PubMed Web of Science ®Google Scholar
• Nebbioso A , TambaroFP , Dell’AversanaC , AltucciL. Cancer epigenetics: moving forward. PLOS Genet.14, 6 (2018).
   Web of Science ®Google Scholar
• Yang Q , YangY , ZhouNet al. Epigenetics in ovarian cancer: premise, properties, and perspectives. Mol. Cancer17(1), 1–21 (2018).
   PubMedGoogle Scholar
• Shukla S , MeeranSM , KatiyarSK. Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention. Cancer Lett.355(1), 9–17 (2014).
   PubMed Web of Science ®Google Scholar
• Kaufman-Szymczyk A , MajewskiG , Lubecka-PietruszewskaK , Fabianowska-MajewskaK. The role of sulforaphane in epigenetic mechanisms, including interdependence between histone modification and DNA methylation. Int. J. Mol. Sci.16(12), 29732–29743 (2015).
   PubMed Web of Science ®Google Scholar
• Sanaei M , KavoosiF. Histone deacetylases and histone deacetylase inhibitors: molecular mechanisms of action in various cancers. Adv. Biomed. Res.8, 63 (2019).
   PubMedGoogle Scholar
• Fernandes J , AcuñaSM , AokiJI , Floeter-WinterLM , MuxelSM. Long non-coding RNAs in the regulation of gene expression: physiology and disease. Noncoding RNA5(1), 17 (2019).
   PubMed Web of Science ®Google Scholar
• Oliveto S , MancinoM , ManfriniN , BiffoS. Role of microRNAs in translation regulation and cancer. World J. Biol. Chem.8(1), 45–56 (2017).
   PubMedGoogle Scholar
• Michlewski G , CáceresJF. Post-transcriptional control of miRNA biogenesis. RNA (New York, NY)25(1), 1–16 (2019).
   PubMed Web of Science ®Google Scholar
• Pardini B , DeMaria D , FrancavillaA , DiGaetano C , RoncoG , NaccaratiA. MicroRNAs as markers of progression in cervical cancer: a systematic review. BMC Cancer18, 1 (2018).
   PubMed Web of Science ®Google Scholar
• Svoronos AA , EngelmanDM , SlackFJ. OncomiR or tumour suppressor? The duplicity of MicroRNAs in cancer.Cancer Res.76(13), 3666–3670 (2016).
   PubMed Web of Science ®Google Scholar
• miRBase: the microRNA database . https://mirbase.org/
   Google Scholar
• Kamińska K , NalejskaE , KubiakMet al. Prognostic and predictive epigenetic biomarkers in oncology. Mol. Diagn. Ther.23(1), 83–95 (2019).
   PubMed Web of Science ®Google Scholar
• Durzynska J , LesniewiczK , PorebaE. Human papillomaviruses in epigenetic regulations. Mutat. Res. Mutat. Res.772, 36–50 (2017).
   PubMed Web of Science ®Google Scholar
• Do H , KimW. Roles of oncogenic long non-coding RNAs in cancer development. Genomics Informat.16, 4 (2018).
   Google Scholar
• Dong J , SuM , ChangW , ZhangK , WuS , XuT. Long non-coding RNAs on the stage of cervical cancer (Review). Oncol. Rep.38, 1923–1931 (2017).
   PubMed Web of Science ®Google Scholar
• Li B , LiB. The role of lncRNAs in the development of endometrial carcinoma (Review). Oncol. Lett.16, 3424–3429 (2018).
   PubMed Web of Science ®Google Scholar
• Zhang X , MaoL , LiL , HeZ , WangN , SongY. Long noncoding RNA GIHCG functions as an oncogene and serves as a serum diagnostic biomarker for cervical cancer. J. Cancer10(3), 672–681 (2019).
   PubMed Web of Science ®Google Scholar
• Alfaro-Mora Y , HerreraLA , Cáceres-GutiérrezR , Andonegui-ElgueraMA , Dominguez-GómezG , D’iaz-ChávezJ. Role of Epigenetics in Cervical Cancer.Gynaecological Malignancies – Updates and Advances, IntechOpen,London, UK (2019).
   Google Scholar
• Cicchini L , WestrichJA , XuTet al. Suppression of antitumour immune responses by human papillomavirus through epigenetic downregulation of CXCL14. mBio7(3), 216–270 (2016).
   Web of Science ®Google Scholar
• Bashaw AA , LeggattGR , ChandraJ , TuongZK , FrazerIH. Modulation of antigen presenting cell functions during chronic HPV infection. Papillomavirus Res. (Amsterdam, The Netherlands)4, 58–65 (2017).
   PubMedGoogle Scholar
• Landoni F , ColomboA , MilaniR , PlacaF , ZanagnoloV , MangioniC. Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update. J. Gynecol. Oncol.28, 3 (2017).
   Web of Science ®Google Scholar
• Shim S-H , LimMC , KimHJet al. Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation. PLOS ONE 13, 1 (2018).
   Web of Science ®Google Scholar
• Tseng JH , AloisiA , SonodaYet al. Long-term oncologic outcomes of uterine-preserving surgery in young women with stage ib1 cervical cancer. Int. J. Gynecol. Cancer28(7), 1350–1359 (2018).
   PubMed Web of Science ®Google Scholar
• Ventola CL . Cancer Immunotherapy, Part 2: Efficacy, safety, and other clinical considerations. PT42(7), 452–463 (2017).
   PubMedGoogle Scholar
• Jordan K , FeyerP , H’OllerU , LinkH , W’OrmannB , JahnF. Supportive treatments for patients with cancer. Deutsches Arzteblatt Int.114(27–28), 481–487 (2017).
   PubMed Web of Science ®Google Scholar
• Goktas SB , GunI , YildizT , SakarMN , CaglayanS. The effect of total hysterectomy on sexual function and depression. Pakistan J. Med. Sci.31(3), 700–705 (2015).
   PubMed Web of Science ®Google Scholar
• Pfaendler KS , TewariKS. Changing paradigms in the systemic treatment of advanced cervical cancer. Am. J. Obstet. Gynecol.214(1), 2 (2016).
   Web of Science ®Google Scholar
• Cho O , ChunM. Management for locally advanced cervical cancer: new trends and controversial issues. Radiat. Oncol. J.36(4), 254–264 (2018).
   PubMedGoogle Scholar
• Mishra GA , PimpleSA , ShastriSS. An overview of prevention and early detection of cervical cancers. Indian J. Med. Paediatr. Oncol.32(3), 125–132 (2011).
   PubMedGoogle Scholar
• Baylin SB , JonesPA. Epigenetic determinants of cancer. Cold Spring Harbor Persp.Biol.8, 9 (2016).
   Web of Science ®Google Scholar
• Suraweera A , O’ByrneKJ , RichardDJ. Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi. Front. Oncol.8, 92 (2018).
   PubMed Web of Science ®Google Scholar
• Martin SL , RoystonKJ , TollefsbolTO. The Role of Non-Coding RNAs and Isothiocyanates in Cancer. Mol. Nutr. Food Res.62, 18 (2018).
   Web of Science ®Google Scholar
• Ribeiro ML , Reyes-GarauD , ArmengolM , Fernández-SerranoM , RouéG. Recent advances in the targeting of epigenetic regulators in B-cell non-Hodgkin lymphoma. Front. Genet.10, 986 (2019).
   PubMed Web of Science ®Google Scholar
• Kronfol MM , DozmorovMG , HuangR , SlattumPW , McClayJL. The role of epigenomics in personalized medicine. Expert Rev. Prec. Med. Drug Dev.2(1), 33–45 (2017).
   PubMed Web of Science ®Google Scholar
• Greenwell M , RahmanPK. Medicinal plants: their use in anticancer treatment. Int. J. Pharmaceut. Sci. Res.6(10), 4103–4112 (2015).
   PubMed Web of Science ®Google Scholar
• Barbieri R , CoppoE , MarcheseAet al. Phytochemicals for human disease: an update on plant-derived compounds antibacterial activity. Microbiol. Res.196, 44–68 (2017).
   PubMed Web of Science ®Google Scholar
• Karimi A , MajlesiM , Rafieian-KopaeiM. Herbal versus synthetic drugs; beliefs and facts. J. Nephropharmacol.4(1), 27–30 (2015).
   PubMedGoogle Scholar
• Kapinova A , KubatkaP , GolubnitschajaOet al. Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention. Environ. Health Prev. Med.23(1), 36 (2018).
   PubMed Web of Science ®Google Scholar
• Sharma SB , GuptaR. Drug development from natural resource: a systematic approach. Mini Rev. Med. Chem.1(15), 1 (2015).
   Google Scholar
• Anwar-Mohamed A , El-KadiAOS. Sulforaphane induces CYP1A1 mRNA, protein, and catalytic activity levels via an AhR-dependent pathway in murine hepatoma Hepa 1c1c7 and human HepG2 cells. Cancer Lett.8(275), 1 (2009).
   Google Scholar
• Khan A , SundaramMK , HamzaAet al. Sulforaphane reverses the expression of various tumour suppressor genes by targeting DNMT3B and HDAC1 in human cervical cancer cells. Evidence-Based Complement. Altern. Med.2015, 412149 (2015).
   PubMed Web of Science ®Google Scholar
• Su X , JiangX , MengL , DongX , ShenY , XinY. Anticancer activity of sulforaphane: the epigenetic mechanisms and the Nrf2 signaling pathway. Oxid. Med. Cell Longev.2018, 1–10 (2018).
   Web of Science ®Google Scholar
• Zaman MS , ChauhanN , YallapuMMet al. Curcumin nanoformulation for cervical cancer treatment. Sci. Rep.6, 20051 (2016).
   PubMed Web of Science ®Google Scholar
• Thakur VS , DebG , BabcookMAet al. Plant phytochemicals as epigenetic modulators: role in cancer chemoprevention. AAPS J.16, 151–163 (2014).
   PubMed Web of Science ®Google Scholar
• Kumar D , BasuS , ParijaLet al. Curcumin and ellagic acid synergistically induce ROS generation, DNA damage, p53 accumulation and apoptosis in HeLa cervical carcinoma cells. Biomed. Pharmacother.81, 31–37 (2016).
   PubMed Web of Science ®Google Scholar
• Kim E , BissonWH , L’OhrCVet al. Histone and non-histone targets of dietary deacetylase inhibitors. Curr. Topics Med. Chem.16(7), 714–731 (2016).
   PubMed Web of Science ®Google Scholar
• Guo H , ZhangD , FuQ. Inhibition of cervical cancer by promoting IGFBP7 expression using ellagic acid from pomegranate peel. Med. Sci. Monit.22, 4881–4886 (2016).
   PubMed Web of Science ®Google Scholar
• Tuli HS , TuorkeyMJ , ThakralFet al. Molecular mechanisms of action of genistein in cancer: recent advances. Front. Pharmacol.10, 1336 (2019).
   PubMed Web of Science ®Google Scholar
• Abotaleb M , SamuelSM , VargheseEet al. Flavonoids in cancer and apoptosis. Cancers28, 11 (2018).
   Google Scholar
• Farhan M , UllahMF , FaisalMet al. Differential methylation and acetylation as the epigenetic basis of resveratrol’s anticancer activity. Medicines (Basel, Switzerland)6(1), 24 (2019).
   PubMedGoogle Scholar
• Yu X , LiuY , WangY , MaoX , ZhangY , XiaJ. Baicalein induces cervical cancer apoptosis through the NF-κB signaling pathway. Mol. Med. Rep.17(4), 5088–5094 (2018).
   PubMed Web of Science ®Google Scholar
• Clemente-Soto AF , Salas-VidalE , Milan-PachecoC , Sánchez-CarranzaJN , Peralta-ZaragozaO , González-MayaL. Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression-independent manner in HPV-positive human cervical cancer-derived cells. Mol. Med. Reports1(19), 3 (2019).
   Google Scholar
• Sundaram MK , HussainA , HaqueS , RainaR , AfrozeN. Quercetin modifies 5′CpG promoter methylation and reactivates various tumour suppressor genes by modulating epigenetic marks in human cervical cancer cells. J. Cell. Biochem.120(10), 18357–18369 (2019).
   PubMed Web of Science ®Google Scholar
• Palliyaguru DL , YuanJM , KenslerTW , FaheyJW. Isothiocyanates: translating the power of plants to people. Mol. Nutr. Food Res.62, 18 (2018).
   Web of Science ®Google Scholar
• Mokhtari RB , NargesBaluch N , HomayouniTSet al. The role of sulforaphane in cancer chemoprevention and health benefits: a mini-review. J. Cell Comm. Signal.12(1), 91–101 (2018).
   PubMed Web of Science ®Google Scholar
• Jiang X , LiuY , MaLet al. Chemopreventive activity of sulforaphane. Drug design. Dev. Ther.12, 2905–2913 (2018).
   PubMed Web of Science ®Google Scholar
• Cheng YM , TsaiCC , HsuYC. Sulforaphane, a dietary isothiocyanate, induces G2/M arrest in cervical cancer cells through CyclinB1 downregulation and GADD45β/CDC2 association. Int. J. Mol. Sci.17, 9 (2016).
   Web of Science ®Google Scholar
• Sharma C , SadriehL , PriyaniA , AhmedM , HassanAH , HussainA. Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells. Cancer Epidemiol.1(35), 3 (2011).
   Google Scholar
• Park SY , KimGY , BaeSJ , YooYH , ChoiYH. Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3. Oncol. Reports1(18), 1 (2007).
   Google Scholar
• Schnekenburger M , DiederichM. Nutritional epigenetic regulators in the field of cancer. Epigenetic Cancer Ther.2015, 393–425 (2015).
   Google Scholar
• Wang S , WangY , LiuX , YangY , WuS , SfnLY. SFN enhanced the radiosensitivity of cervical cancer cells via activating LATS2 and blocking Rad51/MDC1 recruitment to DNA damage site. Cancers8, 14 (2022).
   Google Scholar
• Woodward KA , DraijerR , ThijssenDHJ , LowDA. Polyphenols and microvascular function in humans: a systematic review. Curr. Pharm. Des.24(2), 203–226 (2018).
   PubMed Web of Science ®Google Scholar
• Sundaram MK , AnsariMZ , AlMutery Aet al. Genistein induces alterations of epigenetic modulatory signatures in human cervical cancer cells. Anticancer Agents Med. Chem.2018(18), 412–421 (2018).
   Google Scholar
• Hassan FU , RehmanMS , KhanMSet al. Curcumin as an alternative epigenetic modulator: mechanism of action and potential effects. Front. Genet.4, 10 (2019).
   Google Scholar
• Lewinska A , AdamczykJ , PajakJet al. Curcumin-mediated decrease in the expression of nucleolar organizer regions in cervical cancer (HeLa) cells. Mutat. Res. Toxicol. Environ. Mutagen.771, 43–52 (2014).
   PubMed Web of Science ®Google Scholar
• Khojaste E , AhmadizadehC. Catechin metabolites along with curcumin inhibit proliferation and induce apoptosis in cervical cancer cells by regulating VEGF expression in-vitro. Nutr. Cancer24(74), 3 (2022).
   Google Scholar
• Wang T , WuX , SongY , ChengH. Curcumin induces G2/M arrest and triggers autophagy, ROS generation and cell senescence in cervical cancer cells. J. Cancer11, 22 (2020).
   Web of Science ®Google Scholar
• Zhao X , ZhangR , SongZet al. Curcumin suppressed the proliferation and apoptosis of HPV-positive cervical cancer cells by directly targeting the E6 protein. Phyther. Res. doi: 10.1002/ptr.7868 (2023). ( Epub ahead of print).
   Web of Science ®Google Scholar
• Ismail T , CalcabriniC , DiazARet al. Ellagitannins in cancer chemoprevention and therapy. Toxins8(5), 151 (2016).
   PubMed Web of Science ®Google Scholar
• Khiewkamrop P , PhunsomboonP , RichertLet al. E catechins. EGCG and EC facilitate apoptosis induction through targeting de novo lipogenesis pathway in HepG2 cells. Cancer Cell Int.18, 46 (2018).
   PubMed Web of Science ®Google Scholar
• Wang Y-Q , LuJ-L , LiangY-R , LiQ-S. Suppressive effects of EGCG on cervical cancer. Molecules23(9), 2334 (2018).
   PubMed Web of Science ®Google Scholar
• Alshatwi AA , PeriasamyVS , AthinarayananJ , ElangoR. Synergistic anticancer activity of dietary tea polyphenols and bleomycin hydrochloride in human cervical cancer cell: caspase-dependent and independent apoptotic pathways. Chem. Biol. Interact.247, 1–10 (2016).
   PubMed Web of Science ®Google Scholar
• Qiao Y , CaoJ , XieL , ShiX. Cell growth inhibition and gene expression regulation by (-)-epigallocatechin-3-gallate in human cervical cancer cells. Arch. Pharmacal Res.32, 1309–1315 (2009).
   PubMed Web of Science ®Google Scholar
• Asif Siddiqui F , NaimM , IslamN. Apoptotic effect of green tea polyphenol (EGCG) on cervical carcinoma cells. Diagn. Cytopathol.39(7), 482–488 (2011).
   PubMed Web of Science ®Google Scholar
• Montgomery M , SrinivasanA. Epigenetic gene regulation by dietary compounds in cancer prevention. Adv. Nutr.10(6), 1012–1028 (2019).
   PubMed Web of Science ®Google Scholar
• Sundaram MK , HaqueS , SomvanshiP , BhardwajT , HussainA. Epigallocatechin gallate inhibits HeLa cells by modulation of epigenetics and signaling pathways. 3 Biotech.10(11), 484 (2020).
   PubMedGoogle Scholar
• Zhu Y , HuangY , LiuMet al. Epigallocatechin gallate inhibits cell growth and regulates miRNA expression in cervical carcinoma cell lines infected with different high-risk human papillomavirus subtypes. Exp. Ther. Med.1(17), 3 (2019).
   Google Scholar
• Kř\’\ižová L , DadákováK , KašparovskáJ , KašparovskýT. Isoflavones. Molecules (Basel, Switzerland)24(6), 1076 (2019).
   PubMed Web of Science ®Google Scholar
• Hajialyani M , FarzaeiMH , EcheverríaJet al. Hesperidin as a neuroprotective agent: a review of animal and clinical evidence. Molecules (Basel, Switzerland)24(3), 648 (2019).
   PubMed Web of Science ®Google Scholar
• Panche AN , DiwanAD , ChandraSR. Flavonoids: an overview. J. Nutr. Sci.5, e47 (2016).
   PubMed Web of Science ®Google Scholar
• Cirmi S , FerlazzoN , LombardoGEet al. Chemopreventive agents and inhibitors of cancer hallmarks: may citrus offer new perspectives?. Nutrients8(11), 698 (2016).
   PubMed Web of Science ®Google Scholar
• Pandey P , KhanF , MauryaP. Targeting Jab1 using hesperidin (dietary phytocompound) for inducing apoptosis in HeLa cervical cancer cells. J. Food Biochem.45, 7 (2021).
   Web of Science ®Google Scholar
• Abu-Amero KK , KondkarAA , ChalamKV. Resveratrol and ophthalmic diseases. Nutrients8(4), 200 (2016).
   PubMed Web of Science ®Google Scholar
• Salehi B , MishraAP , NigamMet al. Resveratrol: a double-edged sword in health benefits. Biomedicines6(3), 91 (2018).
   PubMed Web of Science ®Google Scholar
• Resveratrol RG . Multiple activities on the biological functionality of the cell. Nutraceuticals1, 453–464 (2016).
   Google Scholar
• Ko JH , SethiG , UmJYet al. The role of resveratrol in cancer therapy. Int. J. Mol. Sci.18(12), 2589 (2017).
   PubMed Web of Science ®Google Scholar
• Saghafi T , TaheriRA , ParkkilaS , EmamehRZ. Phytochemicals as modulators of long non-coding RNAs and inhibitors of cancer-related carbonic anhydrases. Int. J. Mol. Sci.20(12), 2939 (2019).
   PubMed Web of Science ®Google Scholar
• Zhang P , LiH , YangBet al. Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells. Genes Cancer5, 5–6 (2014).
   Google Scholar
• Saenglee S , JogloyS , PatanothaiA , LeidM , SenawongT. Cytotoxic effects of peanut phenolics possessing histone deacetylase inhibitory activity in breast and cervical cancer cell lines. Pharmacol. Reports68, 1102–1110 (2016).
   PubMed Web of Science ®Google Scholar
• Liu Z , LiY , SheGet al. Resveratrol induces cervical cancer HeLa cell apoptosis through the activation and nuclear translocation promotion of FOXO3a. Die. Pharm. Int. J. Pharm. Sci.1(75), 6 (2020).
   Google Scholar
• Jiang B , TianQ , ShuC , ZhaoJ , XueM , ZhuS. Resveratrol enhances the anti-cancer effects of cis-platinum on human cervical cancer cell lines by activating the SIRT3 relative anti-oxidative pathway. Front. Pharmacol.5, 13 (2022).
   Google Scholar
• Li L , QiuRL , LinYet al. Resveratrol suppresses human cervical carcinoma cell proliferation and elevates apoptosis via the mitochondrial and p53 signaling pathways. Oncol. Lett.1(15), 6 (2018).
   Google Scholar
• Chen RJ , KuoHC , ChengLHet al. Apoptotic and nonapoptotic activities of pterostilbene against cancer. Int. J. Mol. Sci.18, 19 (2018).
   Google Scholar
• Asensi M , MedinaI , OrtegaAet al. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic. Biol. Med.1(33), 3 (2002).
   Google Scholar
• Chatterjee K , AlSharifD , MazzaC , SyarP , AlSharif M , FataJE. Resveratrol and pterostilbene exhibit anticancer properties involving the downregulation of HPV oncoprotein E6 in cervical cancer cells. Nutrients21, 10 (2018).
   Google Scholar
• Shin HJ , HanJM , ChoiYS , JungHJ. Pterostilbene suppresses both cancer cells and cancer stem-like cells in cervical cancer with superior bioavailability to resveratrol. Molecules6, 25 (2020).
   Google Scholar
• Kim YJ , KimHJ , LeeJY , KimDH , KangMS , ParkW. Anti-inflammatory effect of baicalein on polyinosinic-polycytidylic acid-induced RAW 264.7 mouse macrophages. Viruses10(5), 224 (2018).
   PubMed Web of Science ®Google Scholar
• Liao C-Y , LeeC-C , TsaiCet al. Novel investigations of flavonoids as chemopreventive agents for hepatocellular carcinoma. Biomed. Res. Int.2015(4), 1–26 (2015).
   Google Scholar
• Yu X , YangY , LiYet al. Baicalein inhibits cervical cancer progression via downregulating long noncoding RNA BDLNR and its downstream PI3 K/Akt pathway. Int. J. Biochem. Cell Biol.94, 107–118 (2018).
   PubMed Web of Science ®Google Scholar
• Yang J , NieJ , MaXet al. Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol. Cancer18, 26 (2019).
   PubMed Web of Science ®Google Scholar
• Lei H , ShiJ , TengYet al. Baicalein modulates the radiosensitivity of cervical cancer cells in vitro via miR-183 and the JAK2/STAT3 signaling pathway. Adv. Clin. Exp. Med.30(7), 727–736 (2021).
   PubMed Web of Science ®Google Scholar
• Wu X , YangZ , DangH , PengH , DaiZ. Baicalein inhibits the proliferation of cervical cancer cells through the GSK3β-dependent pathway. Oncol. Res. Featur. Preclin. Clin. Cancer Ther.7(26), 4 (2018).
   Google Scholar
• Xia X , XiaJ , YangHet al. Baicalein blocked cervical carcinoma cell proliferation by targeting CCND1 via Wnt/β-catenin signaling pathway. Artif. Cell, Nanomed. Biotechnol.4(47), 1 (2019).
   Google Scholar
• Yu X , LuK , XiaJ , MaoX. Baicalein induces HeLa cell growth inhibition by down-regulation of matrix metalloproteinases and activating extracellular signal-regulated kinase. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi: Chinese J. Cell Mol. Immunol.1(30), 8 (2014).
   Google Scholar
• David AVA , ArulmoliR , ParasuramanS. Overviews of biological importance of quercetin: a bioactive flavonoid. Pharmaco. Rev.10(20), 84–89 (2016).
   PubMedGoogle Scholar
• Shafabakhsh R , AsemiZ. Quercetin: a natural compound for ovarian cancer treatment. J. Ovarian Res.12, 55 (2019).
   PubMed Web of Science ®Google Scholar
• Hashemzaei M , FarAD , YariAet al. Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo. Oncol. Rep.38(2), 819–828 (2017).
   PubMed Web of Science ®Google Scholar
• Alvarez MC , MasoV , TorelloCOet al. The polyphenol quercetin induces cell death in leukemia by targeting epigenetic regulators of pro-apoptotic genes. Clin. Epigenet10, 139 (2018).
   PubMed Web of Science ®Google Scholar
• Fernández-Palanca P , FondevilaF , Méndez-BlancoC , TuñónMJ , González-GallegoJ , MaurizJL. Antitumor effects of quercetin in hepatocarcinoma in vitro and in vivo models: a systematic review. Nutrients11, 12 (2019).
   Web of Science ®Google Scholar
• He C , LuX , LiJet al. The effect of quercetin on cervical cancer cells as determined by inducing tumor endoplasmic reticulum stress and apoptosis and its mechanism of action. Am. J. Transl. Res.13, 5 (2021).
   Web of Science ®Google Scholar
• Murata M , KomatsuS , MiyamotoEet al. Quercetin up-regulates the expression of tumor-suppressive microRNAs in human cervical cancer. Biosci. Microbiota, Food Heal.42(1), 87–93 (2023).
   PubMed Web of Science ®Google Scholar
• Chan CW , DeadmanBJ , Manley-HarrisM , WilkinsAL , AlberDG , HarryE. Analysis of the flavonoid component of bioactive New Zealand mānuka (Leptospermum scoparium) honey and the isolation, characterisation and synthesis of an unusual pyrrole. Food Chem.141(3), 1772–1781 (2013).
   PubMed Web of Science ®Google Scholar
• Woźniak M , MrówczyńskaL , Kwaśniewska-SipP , WaśkiewiczA , NowakP , RatajczakI. Effect of the solvent on propolis phenolic profile and its antifungal, antioxidant, and in vitro cytoprotective activity in human erythrocytes under oxidative stress. Molecules17, 25 (2020).
   Google Scholar
• Batra P , SharmaAK. Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech.3(6), 439–459 (2013).
   PubMedGoogle Scholar
• Pal-Bhadra M , RamaiahMJ , ReddyTLet al. Plant HDAC inhibitor chrysin arrest cell growth and induce p21 WAF1 by altering chromatin of STAT response element in A375 cells. BMC Cancer12, 1–7 (2012).
   PubMed Web of Science ®Google Scholar
• Pawar JS , MustafaS , ChrysinGI. Chrysin and capsaicin induces premature senescence and apoptosis via mitochondrial dysfunction and p53 elevation in cervical cancer cells. Saudi J. Biol. Sci.1(29), 5 (2022).
   Google Scholar
• Laishram S , MoirangthemDS , BorahJCet al. Chrysin rich Scutellaria discolor Colebr. induces cervical cancer cell death via the induction of cell cycle arrest and caspase-dependent apoptosis. Life Sci.15(143), 105–113 (2015).
   Google Scholar
• Raina R , AfrozeN , SundaramMKet al. Chrysin inhibits propagation of HeLa cells by attenuating cell survival and inducing apoptotic pathways. Eur. Rev. Med. Pharmacol. Sci.1(25), 5 (2021).
   Google Scholar
• Yu Y , ZickS , LiX , ZouP , WrightB , SunD. Examination of the pharmacokinetics of active ingredients of ginger in humans. AAPS J.13, 417–426 (2011).
   PubMed Web of Science ®Google Scholar
• Wang W , LiCY , WenXD , LiP , WiL-W. Simultaneous determination of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol in rat plasma by liquid chromatography–mass spectrometry: application to pharmacokinetics. J. Chromatogr. B.15(877), 671–679 (2009).
   Google Scholar
• Oyagbemi AA , SabaAB , AzeezOI. Molecular targets of [6]-gingerol: Its potential roles in cancer chemoprevention. Biofactors36(3), 169–178 (2010).
   PubMed Web of Science ®Google Scholar
• Rastogi N , DuggalS , SinghSKet al. Proteasome inhibition mediates p53 reactivation and anti-cancer activity of 6-gingerol in cervical cancer cells. Oncotarget12, 6 (2015).
   Google Scholar
• Liu Y , WhelanRJ , PattnaikBRet al. Terpenoids from Zingiber officinale (ginger) induce apoptosis in endometrial cancer cells through the activation of p53. PLOS ONE31, 7 (2012).
   Google Scholar
• Rastogi N , GaraRK , TrivediRet al. (6)-Gingerolinduced myeloid leukemia cell death is initiated by reactive oxygen species and activation of miR-27b expression. Free Radic. Biol. Med.1(68), 288–301 (2014).
   Google Scholar
• Lv C , HongY , MiaoLet al. Wentilactone A as a novel potential antitumor agent induces apoptosis and G2/M arrest of human lung carcinoma cells, and is mediated by HRas-GTP accumulation to excessively activate the Ras/Raf/ERK/p53-p21 pathway. Cell Death Dis.4, 12 (2013).
   Web of Science ®Google Scholar
• Zhang F , ZhangJG , QuJ , ZhangQ , PrasadC , WeiZ-J. Assessment of anti-cancerous potential of 6-gingerol (Tongling white ginger) and its synergy with drugs on human cervical adenocarcinoma cells. Food Chem. Toxicol.1(109), 910–922 (2017).
   Google Scholar
• Ahmed SH , GondaT , HunyadiA. Medicinal chemistry inspired by ginger: exploring the chemical space around 6-gingerol. RSC Adv.11(43), 26687–26699 (2021).
   PubMed Web of Science ®Google Scholar
• Liu Q , PengYB , QiLWet al. The cytotoxicity mechanism of 6-shogaol-treated HeLa human cervical cancer cells revealed by label-free shotgun proteomics and bioinformatics analysis. Evid. Based Complement. Altern. Med.1, 2012 (2012).
   Google Scholar
• Pei XD , HeZL , YaoHLet al. 6-Shogaol from ginger shows anti-tumor effect in cervical carcinoma via PI3K/Akt/mTOR pathway. Eur. J. Nutr.1, 1–3 (2021).
   Google Scholar
• Wei QY , HeKM , ChenJL , XuYM , LauA. Phytofabrication of nanoparticles as novel drugs for anticancer applications. Molecules (Basel, Switzerland)24(23), 4246 (2019).
   PubMed Web of Science ®Google Scholar
• Altemimi A , LakhssassiN , BaharloueiA , WatsonDG , LightfootDA. Phytochemicals: extraction, isolation, and identification of bioactive compounds from plant extracts. Plants (Basel, Switzerland)6(4), 42 (2017).
   PubMedGoogle Scholar
• Bode AM , DongZ. Toxic phytochemicals and their potential risks for human cancer. Cancer Prev. Res. (Philadelphia, PA)8(1), 1–8 (2015).
   PubMed Web of Science ®Google Scholar